Prudential Financial
AVNR

Prudential Financial’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Prudential Financial’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-20,469
Closed -$347K – 2296
2014
Q4 		$347K Buy
20,469
+4,100
+25% +$57.7K ﹤0.01% 2005
2014
Q3 		$195K Sell
16,369
-14,728
-47% -$101K ﹤0.01% 2131
2014
Q2 		$175K Buy
31,097
+16,328
+111% +$75.2K ﹤0.01% 2300
2014
Q1 		$54K Sell
14,769
-500
-3% -$1.91K ﹤0.01% 2229
2013
Q4 		$51K Sell
15,269
-600
-4% -$2.48K ﹤0.01% 2256
2013
Q3 		$67K Buy
15,869
+500
+3% +$2.37K ﹤0.01% 2241
2013
Q2 		$71K Buy
+15,369
New +$52.8K ﹤0.01% 2241

Prudential Financial's AVNR Position: Q1 2015 in Review

Prudential Financial sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 20,469 shares — an estimated $347K sold.

Prudential Financial first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $347K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Prudential Financial reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Prudential Financial sold 20,469 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $347K.
  • Prudential Financial first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Prudential Financial's AVANIR PHARMACEUTICALS, INC CL A position peaked at $347K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Prudential Financial's 13F filing for Q1 2015, filed 1 May 2015.